SEC 13F Intelligence

Managers / Q1 2019 · view latest →

Cheyne Capital Management (UK) LLP

CIK 0001390457 · STORNOWAY HOUSE, 13 CLEVELAND ROW, LONDON, X0, SW1A 1DH · 011-44(0)2070317450

Reported Value
$107M
Q1 2019
Positions
35
Filings on Record
22
2019–present window
Filed
May 10, 2019
original filing

Summary

Cheyne Capital Management (UK) LLP reported $107M in U.S.-listed holdings across 35 positions for Q1 2019.

Its largest position, CVNA, represents 8.6% of the portfolio.

Compared with Q4 2018, the fund opened 8 new positions and exited 8.

Portfolio Metrics

Turnover
+27.8%
vs prior filed quarter
Top-10 Concentration
+56.7%
share of reported value
Largest Position
+8.6%
Carvana
New / Exited
8 / 8
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $106MQ4 ’18Q1 ’19: $107MQ2 ’19: $138MQ3 ’19: $158MQ3 ’19Q4 ’19: $165MQ1 ’20: $97MQ2 ’20: $148MQ2 ’20Q3 ’20: $203MQ4 ’20: $198MQ1 ’21: $158MQ1 ’21Q2 ’21: $220MQ3 ’21: $168MQ4 ’21: $154MQ4 ’21Q1 ’22: $159MQ2 ’22: $118MQ3 ’22: $47MQ3 ’22Q4 ’22: $57MQ1 ’23: $32MQ2 ’23: $27MQ2 ’23Q3 ’23: $35MQ4 ’23: $28Mfilingsflow.com

Portfolio Composition

By security type
US DOMESTIC: 57.8%Common Stock: 22.3%YANKEE: 7.8%PRIV PLACEMENT: 4.7%Other: 2.6%Other: 4.7%
  • US DOMESTIC · 57.8% · $62M
  • Common Stock · 22.3% · $24M
  • YANKEE · 7.8% · $8M
  • PRIV PLACEMENT · 4.7% · $5M
  • Other · 2.6% · $3M
  • Other · 4.7% · $5M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2018 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
NUTANIX INCNEW+5.45M5.45M+$6M$6M
LIVE NATION ENTERTAINMENT INNEW+4.80M4.80M+$6M$6M
RTI INTL METALS INCNEW+4.25M4.25M+$4M$4M
GTT COMMUNICATIONS INCNEW+79.6K79.6K+$3M$3M
CTRIP COM INTL LTDNEW+2.20M2.20M+$2M$2M
DANAHER CORPORATIONNEW+2.0K2.0K+$2M$2M
ISHARES TRNEW+447447+$350,000$350,000
NUVASIVE INCNEW+4.00M4.00M+$6,000$6,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2019

34 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CVNACARVANA COhistory →CARVANA CO8.57%$9M158.0K
2NXP SEMICONDUCTORS N VNOTE 1.000%12/07.85%$8M8.15M
3PRICELINE GRP INCNOTE 0.900% 9/16.73%$7M6.50M
4VECTOR GROUP LTDFRNT 4/15.71%$6M6.00M
5NUTANIX INCNOTE 1/15.43%$6M5.45M
6LIVE NATION ENTERTAINMENT INNOTE 2.500% 3/15.17%$6M4.80M
7LIBERTY MEDIA CORP DELAWARENOTE 1.000% 1/34.69%$5M4.45M
8RDNTRADNET INChistory →COM4.32%$5M372.9K
9ELECTRONICS FOR IMAGING INCNOTE 0.750% 9/04.14%$4M4.50M
10SPIRIT RLTY CAP INC NEWNOTE 3.750% 5/14.07%$4M4.35M
11RTI INTL METALS INCNOTE 1.625%10/13.93%$4M4.25M
12ARES CAP CORPNOTE 3.750% 2/03.17%$3M3.40M
13GUIDEWIRE SOFTWARE INCNOTE 1.250% 3/13.06%$3M3.00M
14GTT COMMUNICATIONS INCCOM2.58%$3M79.6K
15ABXBARRICK GOLD CORPORATIONhistory →COM2.51%$3M196.0K
16CARDTRONICS INCNOTE 1.000%12/02.50%$3M2.70M
17BIOMARIN PHARMACEUTICAL INCNOTE 0.599% 8/02.45%$3M2.55M
18PROSPECT CAPITAL CORPORATIONNOTE 4.950% 7/12.36%$3M2.55M
19APOLLO GLOBAL MGMT LLCCL A SHS2.31%$2M87.4K
20MARRIOTT VACTINS WORLDWID CONOTE 1.500% 9/12.26%$2M2.55M
21NUANCE COMMUNICATIONS INCDBCV 1.000%12/12.23%$2M2.55M
22CTRIP COM INTL LTDNOTE 1.000% 7/02.10%$2M2.20M
23DANAHER CORPORATION4.75 MND CV PFD1.97%$2M2.0K
24ALLSCRIPTS HEALTHCARE SOLUTNNOTE 1.250% 7/01.83%$2M2.00M
25DYCOM INDS INCNOTE 0.750% 9/11.81%$2M2.10M
26IOVAIOVANCE BIOTHERAPEUTICS INChistory →COM1.66%$2M186.5K
27POLARITYTE INCCOM0.99%$1M98.7K
28INSMED INCNOTE 1.750% 1/10.94%$1M1.00M
29GGALGRUPO FINANCIERO GALICIA S ASPONSORED ADR0.60%$638,00025.0K
30FCXFREEPORT-MCMORAN INCCL B0.58%$621,00048.2K
31SLBSCHLUMBERGER LTDCOM0.56%$597,00013.7K
32BCRXBIOCRYST PHARMACEUTICALSCOM0.38%$407,00050.0K
33ORGENESIS INCCOM0.19%$208,00039.0K
34NUVASIVE INCNOTE 2.250% 3/10.01%$6,0004.00M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2023$28M15Feb 12, 202413F-HRchanges · EDGAR ↗
Q3 2023$35M24Oct 27, 202313F-HRchanges · EDGAR ↗
Q2 2023$27M19Jul 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$32M22May 3, 202313F-HRchanges · EDGAR ↗
Q4 2022$57M59Feb 10, 202313F-HRchanges · EDGAR ↗
Q3 2022$47M35Nov 10, 2022RESTATEMENTchanges · EDGAR ↗
Q2 2022$118M108Aug 5, 202213F-HRchanges · EDGAR ↗
Q1 2022$159M142May 10, 202213F-HRchanges · EDGAR ↗
Q4 2021$154M125Jan 26, 202213F-HRchanges · EDGAR ↗
Q3 2021$168M112Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$220M114Aug 12, 202113F-HRchanges · EDGAR ↗
Q1 2021$158M100May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$198M88Feb 10, 202113F-HRchanges · EDGAR ↗
Q3 2020$203M57Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$148M46Aug 12, 202013F-HRchanges · EDGAR ↗
Q1 2020$97M40May 7, 202013F-HRchanges · EDGAR ↗
Q4 2019$165M43Feb 12, 202013F-HRchanges · EDGAR ↗
Q3 2019$158M40Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$138M42Aug 8, 201913F-HRchanges · EDGAR ↗
Q1 2019$107M35May 10, 201913F-HRchanges · EDGAR ↗
Q4 2018$106M35Feb 5, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.